From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Low-Grade Microalbuminuria Predicts Hypertension

Levels of microalbuminuria in people without diabetes or hypertension at baseline predicted incident hypertension and worsening blood pressure.

Microalbuminuria, a marker for glomerular hyperfiltration and endothelial dysfunction, is often seen in patients with diabetes or hypertension. Researchers from the Framingham Heart Study followed 1499 people without diabetes or hypertension to see whether microalbuminuria might predict blood pressure progression and incident hypertension.

After a mean of 2.9 years, 230 study subjects (15%) had developed hypertension, and 499 (33%) had progressed to worse BP categories as defined by standard guidelines. In multivariate analyses, the ratio of albumin to creatinine in the urine predicted incident hypertension. Patients in the highest quartile of albumin/creatinine ratio at baseline had approximately double the risk for hypertension of those in the lowest quartile.

Comment: Although levels of microalbuminuria measured in this study were generally low, they did predict incident hypertension and worsening blood pressure. The authors hypothesize that glomerular endothelial dysfunction, manifested as low-level microalbuminuria, is potentially both a precursor of essential hypertension and an identifier of patients at increased risk for BP progression. Whether measuring microalbuminuria and instituting early intervention can change outcomes remains to be determined.

— Kirsten E. Fleischmann, MD, MPH

Published in Journal Watch General Medicine May 10, 2005

Citation(s):

Wang TJ et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005 Mar 22; 111:1370-6.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2005. Massachusetts Medical Society. All rights reserved.